Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...

Iqvia (IQV) announced a strategic collaboration with Nvidia (NVDA) to help realize the potential of AI in healthcare and life sciences. Discover outperforming stocks and invest smarter with Top ...

(see more details here). IQVIA Holdings Inc. (NYSE:IQV) is a software and project management company that caters to the needs ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work ...

ArisEurope, ICON, Syneos Health, Accenture, IQVIA, Genpact, Cognizant, Paraxel International, Laboratory Corporation of ...

(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) initiated its adjusted earnings and revenue guidance for ...

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...